Terms: = Leukemia AND DEK, D6S231E, 7913, ENSG00000124795, P35659 AND Diagnosis
21 results:
1.
Choi YJ; Min YK; Lee ST; Choi JR; Shin S
Ann Lab Med; 2024 Jul; 44(4):335-342. PubMed ID: 38145892
[TBL] [Abstract] [Full Text] [Related]
2. [Analysis of 7 cases of pediatric acute myeloid leukemia with dek-NUP214 fusion gene].
Li XL; Liu LP; Wan Y; Liu F; Chen X; Ren YY; Ruan M; Guo Y; Zhu XF; Yang WY
Zhonghua Er Ke Za Zhi; 2023 Apr; 61(4):357-362. PubMed ID: 37011983
[No Abstract] [Full Text] [Related]
3. [Prognostic significance of dek-NUP214 fusion gene in patients with acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation].
Gao MG; Fu Q; Qin YZ; Chang YJ; Wang Y; Yan CH; Xu LP; Zhang XH; Huang XJ; Zhao XS
Zhonghua Nei Ke Za Zhi; 2021 Oct; 60(10):868-874. PubMed ID: 34551474
[No Abstract] [Full Text] [Related]
4. diagnosis of rare subtypes of acute myeloid leukaemia and related neoplasms.
George TI; Bajel A
Pathology; 2021 Apr; 53(3):312-327. PubMed ID: 33676766
[TBL] [Abstract] [Full Text] [Related]
5. Myelodysplastic syndrome with t(6;9)(p22;q34.1)/dek-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases.
Fang H; Yabe M; Zhang X; Kim Y; Wu X; Wei P; Chi S; Zheng L; Garcia-Manero G; Shao L; Yuan J; Shen Y; Zheng G; Tang G; Wang W; Loghavi S; Shen Q; Yuan Y; He R; Chen D; Medeiros LJ; Hu S
Mod Pathol; 2021 Jun; 34(6):1143-1152. PubMed ID: 33558656
[TBL] [Abstract] [Full Text] [Related]
6. Role of the dek oncogene in the development of squamous cell carcinoma.
Ishida K; Nakashima T; Shibata T; Hara A; Tomita H
Int J Clin Oncol; 2020 Sep; 25(9):1563-1569. PubMed ID: 32656741
[TBL] [Abstract] [Full Text] [Related]
7. LCMR1 interacts with dek to suppress apoptosis in lung cancer cells.
Xu Y; Liang Z; Li C; Yang Z; Chen L
Mol Med Rep; 2017 Oct; 16(4):4159-4164. PubMed ID: 28765911
[TBL] [Abstract] [Full Text] [Related]
8. [Application of multiplex nested RT- PCR assay for screening the fusion genes in acute myeloid leukemia and its clinical significance].
Xu Y; Gao L; Sun J; Ding Y; Xu Y; Lyu C; Liu W; Wang N; Wang L; Yu L
Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):29-34. PubMed ID: 24602728
[TBL] [Abstract] [Full Text] [Related]
9. Combination of cytogenetic analysis and molecular screening in patients with de novo acute myeloid leukemia.
Geng Z; Zhang H; Wang D; Xiao Y; Wang N; Li C; Huang L; Zhou J
J Huazhong Univ Sci Technolog Med Sci; 2012 Aug; 32(4):501-510. PubMed ID: 22886961
[TBL] [Abstract] [Full Text] [Related]
10. [Combined application of multiplex reverse transcription-polymerase chain reaction and karyotype analysis to detection of clonal chromosomal aberrations in acute myeloid leukemia].
Huang L; Li CR; Zhang H; Sun LS; Liu WL; Zhou JF
Ai Zheng; 2007 Sep; 26(9):1029-33. PubMed ID: 17927867
[TBL] [Abstract] [Full Text] [Related]
11. Identification of differentially expressed genes in tobacco chewing-mediated oral cancer by differential display-polymerase chain reaction.
Nagpal JK; Das BR
Eur J Clin Invest; 2007 Aug; 37(8):658-64. PubMed ID: 17635577
[TBL] [Abstract] [Full Text] [Related]
12. Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 chromosomal translocation in hematologic malignancies.
Huang M; Li C; Liang H; Zhou J; Deng J; Liu W
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(6):661-3. PubMed ID: 17357482
[TBL] [Abstract] [Full Text] [Related]
13. del(6)(p23) in two cases of de novo AML--a new recurrent primary chromosome abnormality.
Anwar Iqbal M; Al-Omar HM; Owaidah T; Al-Humaidan H; Bhuiyan ZA; Sahovic E
Eur J Haematol; 2006 Sep; 77(3):245-50. PubMed ID: 16856925
[TBL] [Abstract] [Full Text] [Related]
14. Denaturing high-performance liquid chromatography: a valid approach for identifying NPM1 mutations in acute myeloid leukemia.
Roti G; Rosati R; Bonasso R; Gorello P; Diverio D; Martelli MF; Falini B; Mecucci C;
J Mol Diagn; 2006 May; 8(2):254-9. PubMed ID: 16645213
[TBL] [Abstract] [Full Text] [Related]
15. [Analysis of dek-CAN fusion gene expression in acute myeloid leukemia patients with 6; 9 chromosome translocation].
Wang YL; Wang T; Xu F; Gang Y; Wang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):232-6. PubMed ID: 16638187
[TBL] [Abstract] [Full Text] [Related]
16. dek-CAN molecular monitoring of myeloid malignancies could aid therapeutic stratification.
Garçon L; Libura M; Delabesse E; Valensi F; Asnafi V; Berger C; Schmitt C; Leblanc T; Buzyn A; Macintyre E
Leukemia; 2005 Aug; 19(8):1338-44. PubMed ID: 15973457
[TBL] [Abstract] [Full Text] [Related]
17. Development of a D-FISH method to detect dek/CAN fusion resulting from t(6;9)(p23;q34) in patients with acute myelogenous leukemia.
Shearer BM; Knudson RA; Flynn HC; Ketterling RP
Leukemia; 2005 Jan; 19(1):126-31. PubMed ID: 15510206
[TBL] [Abstract] [Full Text] [Related]
18. WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients - results from a single-centre study.
Østergaard M; Olesen LH; Hasle H; Kjeldsen E; Hokland P
Br J Haematol; 2004 Jun; 125(5):590-600. PubMed ID: 15147374
[TBL] [Abstract] [Full Text] [Related]
19. Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: an updated meeting report and review.
Potter MN; Cross NC; van Dongen JJ; Saglio G; Oakhill A; Bartram CR; Goldman JM
Leukemia; 1993 Aug; 7(8):1302-14. PubMed ID: 8350633
[TBL] [Abstract] [Full Text] [Related]
20. dek-can rearrangement in translocation (6;9)(p23;q34).
Soekarman D; von Lindern M; van der Plas DC; Selleri L; Bartram CR; Martiat P; Culligan D; Padua RA; Hasper-Voogt KP; Hagemeijer A
Leukemia; 1992 Jun; 6(6):489-94. PubMed ID: 1602786
[TBL] [Abstract] [Full Text] [Related]
[Next]
